Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Preferred Shares (2017 - 2025)

Fortress Biotech (FBIO) has 9 years of Preferred Shares data on record, last reported at $3000.0 in Q3 2025.

  • For Q3 2025, Preferred Shares changed 0.0% year-over-year to $3000.0; the TTM value through Sep 2025 reached $3000.0, changed 0.0%, while the annual FY2024 figure was $3000.0, 0.0% changed from the prior year.
  • Preferred Shares reached $3000.0 in Q3 2025 per FBIO's latest filing, roughly flat from $3000.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $3000.0 in Q1 2021 and bottomed at $3000.0 in Q1 2021.
  • Average Preferred Shares over 5 years is $3000.0, with a median of $3000.0 recorded in 2021.
  • The widest YoY moves for Preferred Shares: up 50.0% in 2021, down 0.0% in 2021.
  • A 5-year view of Preferred Shares shows it stood at $3000.0 in 2021, then changed by 0.0% to $3000.0 in 2022, then changed by 0.0% to $3000.0 in 2023, then changed by 0.0% to $3000.0 in 2024, then changed by 0.0% to $3000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Preferred Shares were $3000.0 in Q3 2025, $3000.0 in Q2 2025, and $3000.0 in Q1 2025.